Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous...

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for the second quarter ending...

PTC Therapeutics, Inc. today announced a corporate update and reported financial results for the second quarter ended June 30, 2014....

-- Third quarter revenue of $398 million declined 6 percent versus prior year -- Adjusted diluted earnings per share for...

Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Wednesday, August 13, 2014 at 10:00...

NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering innovative therapies that transform the lives of patients with rare...

Cardiome Pharma Corp. today announced that it will report financial results for the second quarter ended June 30, 2014 on...

Synergy Pharmaceuticals Inc., today announced its Chairman and Chief Executive Officer, Dr. Gary S. Jacob, will present a corporate update...

Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced...